🔗 Share this article

Texas Attorney General Ken Paxton is suing the makers of Tylenol, claiming the firms concealed potential risks that the medication created to pediatric brain development.

The court filing arrives a month after Donald Trump advocated an unverified association between taking acetaminophen - also known as paracetamol - during pregnancy and autism in offspring.

The attorney general is suing Johnson & Johnson, which previously sold the drug, the sole analgesic suggested for expectant mothers, and Kenvue, which now manufacturers it.

In a official comment, he said they "deceived the public by gaining financially from pain and promoting medication ignoring the dangers."

Kenvue says there is no credible evidence connecting acetaminophen to autism.

"These companies deceived for years, knowingly endangering millions to increase profits," the attorney general, from the Republican party, said.

Kenvue commented that it was "seriously troubled by the spread of false claims on the security of acetaminophen and the likely effects that could have on the welfare of American women and children."

On its online platform, the company also mentioned it had "consistently assessed the relevant science and there is insufficient valid information that indicates a proven link between using paracetamol and autism spectrum disorder."

Organizations representing doctors and health professionals share this view.

The leading OB-GYN organization has stated paracetamol - the main ingredient in Tylenol - is among limited choices for women during pregnancy to address pain and fever, which can create major wellness concerns if left untreated.

"In multiple decades of research on the consumption of acetaminophen in gestation, no reliable research has conclusively proven that the usage of paracetamol in any period of pregnancy results in brain development issues in young ones," the group stated.

The lawsuit cites recent announcements from the previous government in arguing the medication is potentially dangerous.

In recent weeks, Trump generated worry from health experts when he advised women during pregnancy to "fight like hell" not to consume acetaminophen when unwell.

The FDA then published an announcement that medical professionals should consider limiting the use of acetaminophen, while also stating that "a direct connection" between the drug and autism spectrum disorder in young ones has not been proven.

Health Secretary RFK Jr, who supervises the Food and Drug Administration, had promised in spring to undertake "extensive scientific investigation" that would establish the source of autism spectrum disorder in a matter of months.

But authorities cautioned that discovering a unique factor of autism - believed by scientists to be the result of a complicated interplay of inherited and environmental factors - would prove challenging.

Autism spectrum disorder is a type of enduring cognitive variation and disability that affects how people experience and engage with the surroundings, and is identified using physician assessments.

In his court filing, Paxton - aligned with the former president who is campaigning for the Senate - claims Kenvue and J&J "deliberately disregarded and tried to quiet the evidence" around acetaminophen and autism spectrum disorder.

The lawsuit aims to force the corporations "eliminate any promotional materials" that states Tylenol is safe for women during pregnancy.

This legal action mirrors the complaints of a collection of guardians of minors with autism spectrum disorder and attention deficit hyperactivity disorder who filed suit against the producers of acetaminophen in two years ago.

A federal judge dismissed the legal action, saying studies from the plaintiffs' authorities was inconclusive.